| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $432K | — | +202.1% |
| Cost of Revenue | $42K | — | +281.8% |
| Gross Profit | $390K | — | +195.5% |
| R&D Expense | $149K | — | +44.7% |
| SG&A Expense | $2.6M | — | -26.6% |
| Operating Income | -$2.3M | — | +35.2% |
| Pre-tax Income | -$1.9M | — | +60.9% |
| Income Tax | -$175K | — | +75.8% |
| Net Income | -$1.7M | — | +58.4% |
| EPS (Basic) | -$1.39 | — | -286.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $441K | +401.1% | -2.0% |
| Accounts Receivable | $261K | +68.4% | +207.1% |
| Inventory | $62K | -27.9% | -12.7% |
| Current Assets | $1.2M | +220.3% | +46.3% |
| Total Assets | $35.1M | +121.2% | +41.5% |
| Current Liabilities | $19.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | -19.6% |
| Capital Expenditures | $6K | — | -40.0% |
| Investing Cash Flow | -$1.3M | — | — |
| Financing Cash Flow | $4.5M | — | +6057.3% |
| Free Cash Flow | -$2.8M | — | -19.3% |
| +382.7% |
| Total Liabilities | $25.9M | +181.6% | +53.6% |
| Stockholders' Equity | $9.6M | +35.7% | +20.9% |